The Trustees of the Urban Pharmaceuticals Trust – Trademark Portfolio
Entity Type: 17
The Trustees of the Urban Pharmaceuticals Trust holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include FLANAX, FLANAX BACK PAIN RELIEF PATCH, and FLANAX MENSTRUAL PAIN RELIEVER. The owner is based in Arlington, VA.
Suite 700
3033 Wilson Blvd.
Arlington, VA 22201
Showing of trademarks Trademarks
Trademark Classifications
The Trustees of the Urban Pharmaceuticals Trust's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does The Trustees of the Urban Pharmaceuticals Trust have?
The Trustees of the Urban Pharmaceuticals Trust has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does The Trustees of the Urban Pharmaceuticals Trust file in?
The Trustees of the Urban Pharmaceuticals Trust files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are The Trustees of the Urban Pharmaceuticals Trust's most well-known trademarks?
The Trustees of the Urban Pharmaceuticals Trust's registered trademark portfolio includes well-known marks such as FLANAX, FLANAX BACK PAIN RELIEF PATCH, and FLANAX MENSTRUAL PAIN RELIEVER. These are among 3 currently registered trademarks in the portfolio.
What is The Trustees of the Urban Pharmaceuticals Trust's trademark registration success rate?
The Trustees of the Urban Pharmaceuticals Trust has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.